Sign inGet started

Price Ben Gil

Insider CIK 1417915 · RNN Director · NRBO CEO and President · AVII Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
NRBO NeuroBo Pharmaceuticals, I A Award deriv2021-11-032021-11-04616,666— $0616,666SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2019-06-062019-06-073,537— $03,537SEC↗
RNN REXAHN PHARMACEUTICALS, IN P Buy2019-01-292019-01-3115,000$0.61 $9.2K15,000SEC↗
RNN REXAHN PHARMACEUTICALS, IN A Award deriv2018-11-292018-12-03112,878— $0112,878SEC↗
SRPT Sarepta Therapeutics, Inc. P Buy2016-03-142016-03-164,500$16.70 $75.2K42,830SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2016-02-292016-03-0210,500— $010,500SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2016-02-292016-03-021,000— $038,330SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2015-02-272015-03-0315,000— $015,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2015-02-272015-03-031,000— $037,330SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2014-02-282014-03-0415,000— $015,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2014-02-282014-03-041,000— $036,330SEC↗
SRPT Sarepta Therapeutics, Inc. P Buy2013-08-192013-08-20500$31.18 $15.6K35,330SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2013-06-042013-06-0620,000— $020,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2013-06-042013-06-061,000— $034,830SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2012-08-232012-08-275,000— $05,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2012-08-232012-08-27833— $033,830SEC↗
AVII AVI BIOPHARMA INC P Buy2012-03-142012-03-1530,000$1.30 $39.0K197,982SEC↗